Trial Profile
A retrospective study comparing efficacy and safety of dabigatran with warfarin for direct current cardioversion in the treatment of patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin (Primary)
- Indications Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2017 New trial record
- 01 Dec 2016 Results published in the Cardiology and Therapy